Trials / Completed
CompletedNCT00214058
Weekly Carboplatin/Docetaxel for Recurrent Ovarian/Peritoneal Cancer
Phase II Evaluation of Weekly Docetaxel in Combination With Weekly Carboplatin in the Treatment of Recurrent Epithelial Ovarian Carcinoma
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 36 (planned)
- Sponsor
- University of Wisconsin, Madison · Academic / Other
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- —
Summary
The purpose of this study is to determine the safety and efficacy of this regimen in women with ovarian or peritoneal cancer
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Carboplatin | |
| DRUG | Docetaxel |
Timeline
- Start date
- 2002-08-01
- Completion
- 2006-02-01
- First posted
- 2005-09-21
- Last updated
- 2019-11-19
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00214058. Inclusion in this directory is not an endorsement.